Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
24 studies found for:    Open Studies | pancreatic disease | NIDDK
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Studying Patients With Cystic Fibrosis and Other Pulmonary and Pancreatic Disorders
Condition: Cystic Fibrosis
Intervention:
2 Recruiting Stent vs. Indomethacin for Preventing Post-ERCP Pancreatitis
Condition: Post-ERCP Pancreatitis
Interventions: Other: Indomethacin 100 mg rectally immediately after ERCP, NO prophylactic pancreatic stent placement;   Other: Indomethacin 100 mg rectally immediately after ERCP AND prophylactic pancreatic stent placement
3 Recruiting Mesenchymal Stem Cell and Islet Co-transplantation
Conditions: Chronic Pancreatitis;   Diabetes
Intervention: Biological: autologous mesenchymal stromal cell
4 Recruiting Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies
Condition: Pancreatitis
Intervention: Other: Data Management and Monitoring
5 Recruiting Pediatric Longitudinal Cohort Study of Chronic Pancreatitis
Condition: Pancreatitis
Intervention: Other: Data Management and Monitoring
6 Not yet recruiting MRI to Characterize and Predict CF Liver Disease in PUSH Cohort
Conditions: Cystic Fibrosis Liver Disease;   Pancreatic Insufficiency
Intervention: Procedure: MRI
7 Not yet recruiting Longitudinal Assessment of Transient Elastography in Cystic Fibrosis
Condition: Cystic Fibrosis Liver Disease
Intervention: Procedure: Transient Elastography (TE)
8 Recruiting Blood Flow and Vascular Function in Cystic Fibrosis
Condition: Cystic Fibrosis
Interventions: Drug: Acute (1 hour) Sildenafil;   Drug: Sub-Chronic (4 weeks) Sildenafil;   Drug: Placebo
9 Recruiting CSI-Glucagon for Prevention of Hypoglycemia in Children With Congenital Hyperinsulinism
Condition: Congenital Hyperinsulinism
Interventions: Drug: Glucagon;   Other: Placebo
10 Recruiting Natural History of Noncirrhotic Portal Hypertension
Conditions: Cystic Fibrosis;   Immunologic Deficiency Syndrome;   Turner Syndrome;   Congenital Hepatic Fibrosis;   Idiopathic Non-Cirrhotic Portal Hypertension
Intervention:
11 Recruiting Diagnosing and Treating Low Blood Sugar Levels
Conditions: Hypoglycemia;   Insulinoma
Intervention:
12 Recruiting Clearance of 25-hydroxyvitamin D in Cystic Fibrosis
Condition: Cystic Fibrosis
Intervention: Drug: d6-25-hydroxyvitamin D3
13 Recruiting BioEnergetics and Metabolomics in Cystic Fibrosis
Condition: Cystic Fibrosis
Intervention:
14 Recruiting UAB HRFD Core Center: Core A: The Hepato/Renal Fibrocystic Diseases Translational Resource
Conditions: Hepato/Renal Fibrocystic Disease;   Autosomal Recessive Polycystic Kidney Disease;   Joubert Syndrome;   Bardet Biedl Syndrome;   Meckel-Gruber Syndrome;   Congenital Hepatic Fibrosis;   Caroli Syndrome;   Oro-Facial-Digital Syndrome Type I;   Nephronophthisis;   Glomerulocystic Kidney Disease
Intervention:
15 Recruiting Fat Malabsorption in Chronic Pancreatitis
Condition: Chronic Pancreatitis
Intervention: Drug: Creon36™
16 Recruiting Coordinating and Data Management Center for the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer
Conditions: Chronic Pancreatitis;   Diabetes;   Pancreatic Cancer
Intervention: Other: Data Management and Monitoring
17 Recruiting Muscle Accrual and Function in Cystic Fibrosis-Impact of Glucose Intolerance
Condition: Cystic Fibrosis
Intervention:
18 Recruiting Genetic Modifiers of Cystic Fibrosis Related Diabetes
Condition: Cystic Fibrosis Related Diabetes
Intervention:
19 Not yet recruiting Reduction of Nocturnal Hypoglycemia and Hyperglycemia in the Home Using Predictive Algorithms, Pump Suspension, and Insulin Dosing in Children and Young Adolescents
Conditions: Type 1 Diabetes;   Hypoglycemia;   Hyperglycemia;   Artificial Pancreas
Intervention: Device: Hyperglycemia Minimization Algorithm
20 Not yet recruiting The International Diabetes Closed Loop (iDCL) Trial: Main Protocol
Condition: Type1 Diabetes Mellitus
Interventions: Device: Artificial Pancreas;   Other: Sensor Augmented Therapy;   Device: continuous glucose monitor (CGM)

   Previous Page Studies Shown (1-20) Next Page (21-24) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.